Descending Thoracic Aortic Aneurysms: Is There a New Plan A?

The last available evidence suggests that open surgery should be the preferred treatment for intact descending thoracic aortic aneurysms. However, this study recently published in J Am Coll Cardiol, seems to have steered the wheel.

screening aneurisma aorta abdominalIn this study, open surgery was associated to increased early mortality and lower late mortality. Despite this long-term benefit, mean survival favored endovascular repair. This evidence suggests endovascular repair should be the first choice when it comes to intact thoracic aortic aneurysms.

 

This retrospective analysis used propensity score matching to compare 1235 patients undergoing surgery against 2470 patients undergoing endovascular repair between 1999 and 2010, followed up until 2014. The study looked into perioperative mortality and survival. Reinterventions were among the secondary end points.


Read also: Several Features Define a Hostile Neck in AAA patients, but Only One Makes the Difference.


Periprocedural mortality was higher for the surgery group, with differences between high volume (OR: 1.97, CI 95% 1.53 to 2.61) and low volume centers (OR: 3.62 CI 95% 2.88 to 4.51), though this reversed by the end of the study. Despite early and late survival rates, mean survival after the 9-year follow-up was better with endovascular repair (p<0.001). Reintervention risk (a secondary end point) favored surgery.

 

Conclusion

Conventional surgery is associated with higher early mortality and lower late mortality compared against endovascular repair. After a 9-year follow-up, survival favors endovascular repair, which is why this should be the preferred course of action.

 

Original title: Endovascular Versus Open Repair of Intact Descending Thoracic Aortic Aneurysms.

Reference: Peter Chiu et al. J Am Coll Cardiol 2019;73:643–51.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...